The ingredients division of Associated British Foods (ABF) says it will unveil its range of to the Eastern European markets at the FiCEE exhibition, in Prague.
Among the new products being launched at the show is Veron NDL from AB Enzymes, an ABF Ingredients company. This xylanase preparation with additional genetically modified (GM) liolytic activity can be used for the treatment of wheat-flour based noodle product and pasta.
The quality of raw material greatly influences the quality of both Asian noodles and Italian style pasta. AB Enzymes says that the ability of Veron NDL to allow the use of low-cost raw materials while securing consistent results as if more expensive raw materials had been used should provide major cost savings to manufacturers.
"Veron NDL unlocks the strength potential in flour, which prevents overcooking and enables the noodle texture to remain al dente longer," said the company in a statement. "The hermicellulitic and lipolitic enzyme activities in Veron NDL contribute to a more appealing appearance due to an enzymatic whitening effect."
This is complemented by a reduction in speckiness, increased colour stability of fresh noodles, and a lower oil absorption of fresh noodles.
Jane Toombes of ABF Ingredients said that the firm's attendance at the FiCEE was significant.
"Food ingredient manufacturing is progressively expanding out from the UK and US," she said.
"There is terrific interest within the Eastern European Countries to deliver the same exacting standards for food manufacturing, which means these companies need access to the same leading edge ingredient technologies.
"We are keen to work with such companies to help them achieve this, whilst continuing to develop new and innovative ingredient solutions."
ABF Ingredients (ABFI) is a division of Associated British Foods, comprising of a range of innovative ingredient companies including among others AB Enzymes, PGP International, Provesta and Protient.